Target Price | HKD4.73 |
Price | HKD3.34 |
Potential |
41.62%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target Sino Biopharmaceutical 2026 .
The average Sino Biopharmaceutical target price is HKD4.73.
This is
41.62%
register free of charge
HKD6.18
84.95%
register free of charge
HKD2.99
10.51%
register free of charge
|
|
A rating was issued by 27 analysts: 25 Analysts recommend Sino Biopharmaceutical to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sino Biopharmaceutical stock has an average upside potential 2026 of
41.62%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 31.30 | 34.32 |
8.11% | 9.67% | |
EBITDA Margin | 26.04% | 25.56% |
0.66% | 1.83% | |
Net Margin | 6.60% | 9.68% |
27.32% | 46.57% |
24 Analysts have issued a sales forecast Sino Biopharmaceutical 2025 . The average Sino Biopharmaceutical sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Sino Biopharmaceutical EBITDA forecast 2025. The average Sino Biopharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Sino Biopharmaceutical Analysts have issued a net profit forecast 2025. The average Sino Biopharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.11 | 0.18 |
21.43% | 63.64% | |
P/E | 18.89 | |
EV/Sales | 1.97 |
9 Analysts have issued a Sino Biopharmaceutical forecast for earnings per share. The average Sino Biopharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Sino Biopharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.